FDA Approves First Treatment for MAS in Still Disease
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS)…
Methotrexate Adds No Benefit to Adalimumab in Psoriasis
TOPLINE: In adults with psoriasis, adding methotrexate to adalimumab did not improve effectiveness or drug survival compared with…
Dog Exposure Affects Genetic Risk in Eczema, Study Finds
TOPLINE: Children with a genetic variant linked to atopic eczema (rs10214237) appeared less likely to develop the condition…
Funding Gaps Threaten Genomic Advances in Latin America
In Latin America, efforts to implement preventive strategies, diagnostic tools, and personalized treatment for patients with rheumatic diseases…
2025 Begins With 112 Drugs Waiting for Approval in Europe
As of December 31, 2024, a total of 112 drugs remained under evaluation by the European Medicines Agency…
IL-5 Inhibitors May Be Steroid Alternative For Rx of DRESS
TOPLINE: A retrospective case series found that treatment with an interleukin (IL)-5 inhibitor reduced eosinophil levels and improved…